ストックスクリーナーアプリを入手
13.01
3.77%
-0.51
アフターアワーズ：
13.01
前日終値:
$13.52
開ける：
$13.57
24時間の取引高:
294.53K
Relative Volume:
0.64
時価総額：
$449.13M
収益：
$90.44M
当期純損益:
$561.00K
株価収益率:
2,168.33
EPS:
0.006
ネットキャッシュフロー:
$19.19M
1週間 パフォーマンス:
-1.44%
1か月 パフォーマンス:
+16.26%
6か月 パフォーマンス:
+25.82%
1年 パフォーマンス:
+3.67%
1日の値動き範囲:
$12.74
$13.63
1週間の範囲:
$12.74
$13.74
52週間の値動き範囲:
$8.12
$13.74
Delcath Systems Inc Stock (DCTH) Company Profile
名前
Delcath Systems Inc
セクター
電話
(518) 743-8892
住所
566 QUEENSBURY AVENUE, QUEENSBURY, NY
Compare DCTH vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DCTH
Delcath Systems Inc
|
13.01 | 449.13M | 90.44M | 561.00K | 19.19M | 0.006 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-06-28 | 開始されました | Craig Hallum | Buy |
| 2024-05-14 | 開始されました | Stephens | Overweight |
| 2022-07-26 | 再開されました | Canaccord Genuity | Buy |
| 2021-12-10 | 開始されました | H.C. Wainwright | Buy |
| 2021-03-09 | 開始されました | Canaccord Genuity | Buy |
| 2021-01-05 | 開始されました | BTIG Research | Buy |
| 2020-06-01 | 開始されました | Laidlaw | Buy |
すべてを表示
Delcath Systems Inc (DCTH) 最新ニュース
Is Delcath Systems Inc (DCTH) a Bargain After 3.8% Drop? GF Value Says Undervalued - GuruFocus
CCORF Maintains Delcath Systems(DCTH.US) With Buy Rating, Maintains Target Price $21 - Moomoo
Delcath Systems Announces First Patient Dosed in Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Breast Cancer - BioSpace
Delcath doses first patient in breast cancer trial in Milan - Investing.com
$13.513 | Delcath Systems, Inc. Common Stock (DCTH) Stock Price Today - Binance
Delcath Systems (DCTH) Gains 2.12% as Stock Approaches Key Resistance LevelUp Down Volume - dars.gov.et
DCTH Q1 2026 Earnings: EPS Surprises to the Upside as Company Advances Core PipelineEarnings Per Share - dars.gov.et
DCTHDelcath Systems Inc Options - Finviz
Price to sales forward of Delcath Systems, Inc. – NASDAQ:DCTH - TradingView
Avoiding Lag: Real-Time Signals in (DCTH) Movement - Stock Traders Daily
Delcath Systems, Inc.(NasdaqCM:DCTH) added to Russell Microcap Value Benchmark Index - marketscreener.com
Delcath Systems, Inc.(NasdaqCM: DCTH) added to Russell 2000 Value Benchmark - marketscreener.com
Price to book forward of Delcath Systems, Inc. – SWB:DV3R - TradingView
Delcath Systems, Inc.(NasdaqCM: DCTH) added to Russell 2000 Value-Defensive Index - marketscreener.com
Price to earnings forward of Delcath Systems, Inc. – NASDAQ:DCTH - TradingView
Enterprise value to revenue forward of Delcath Systems, Inc. – SWB:DV3R - TradingView
Delcath Systems, Inc.(NasdaqCM: DCTH) added to Russell 2000 Growth-Defensive Index - marketscreener.com
Enterprise value to EBITDA forward of Delcath Systems, Inc. – NASDAQ:DCTH - TradingView
Mettler-Toledo (MTD) soars 3.3%: Is further upside left in the stock? - MSN
Delcath Systems, Inc.(NasdaqCM: DCTH) added to Russell 2500 Value Benchmark - marketscreener.com
Delcath Systems, Inc. Actuals & Estimates (FWB:DV3R) - TradingView
Delcath Systems, Inc. Actuals & Estimates (NASDAQ:DCTH) - TradingView
Delcath Systems, Inc. Actuals & Estimates (LS:A2PT5P) - TradingView
DCTH Forecast — Price Target — Prediction for 2027 - TradingView
Delcath Systems Inc (DCTH) Institutional Confidence - TradingKey
Delcath Systems (DCTH) Surges 5.6% on Above-Average Volume, Tests Key ResistanceChart Pattern Alerts - dars.gov.et
Delcath Systems, Inc. (DCTH) reports Q1 loss, misses revenue estimates - MSN
Delcath Systems Inc (DCTH) Valuation: PE, PB & Fair Value Analysis - TradingKey
Delcath Systems (DCTH) Dips 2% as Stock Approaches Critical SupportHigh Volume Stocks - dars.gov.et
Delcath Systems Inc (DCTH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Delcath Systems Inc (DCTH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Delcath Systems Inc (DCTH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Delcath Systems Inc (DCTH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Delcath Systems Inc (DCTH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Delcath Systems Inc (DCTH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Delcath Systems (DCTH) Rallies 3.7%—Testing Key Resistance at $12.57Covered Call Trade - dars.gov.et
Q1 2026 Delcath Systems Inc Earnings Call Transcript - GuruFocus
Delcath Systems Inc (DCTH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Delcath Systems (DCTH) Q1 2026 Earnings: Narrower-than-Expected Losses Amid Clinical ProgressEarnings Season Preview - dars.gov.et
Delcath Systems (DCTH) Slips 1.5% as Shares Test Critical Support Near $11Sentiment Divergence - dars.gov.et
Delcath Systems, Inc. - MLQ.ai
Delcath Systems, Inc. Stock 12‑Month Price Target Cut to $20.83, Implies 95% Upside - TradingView
European cancer guidelines add Delcath liver therapy for eye melanoma - Stock Titan
Delcath therapy included in European uveal melanoma guidelines - Investing.com
FDA Approval for HEPZATO issued to DELCATH SYSTEMS INC - Quantisnow
(DCTH) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Abbott’s $21bn Bet on Exact Sciences Takes Center Stage at ASCO 2026 - Citeline News & Insights
Delcath Systems Q1 2026 Earnings: Narrowed Loss Surprises, Stock AdvancesCore Business Growth - newsline.com
Delcath Systems Announces Two ASCO 2026 Investigator Initiated Trials-in-Progress Abstracts - BioSpace
Delcath Systems Publishes Two ASCO 2026 Investigator Initiated Trials-in-Progress Abstracts - Moomoo
Q3 2025 Delcath Systems Inc Earnings Call Transcript - GuruFocus
Delcath Systems Inc (DCTH) 財務データ
収益
当期純利益
現金流量
EPS
2.36%
大文字化:
|
ボリューム (24 時間):